SOUTHWEST STROKE CONFERENCE 2019medicine.exeter.ac.uk/media/universityofexeter/medical...We are...
17
SOUTHWEST STROKE CONFERENCE 2019 CONTINUING PROFESSIONAL DEVELOPMENT Friday 13 September 2019 8:30am – 5:00pm Forum Auditorium, Streatham Campus, University of Exeter, EX4 4PT
Transcript of SOUTHWEST STROKE CONFERENCE 2019medicine.exeter.ac.uk/media/universityofexeter/medical...We are...
SOUTHWEST STROKE CONFERENCE 2019
CONTINUINGPROFESSIONALDEVELOPMENT
Friday 13 September 2019 8:30am – 5:00pm Forum Auditorium, Streatham Campus, University of Exeter, EX4 4PT
We are delighted to welcome you to the inaugural Southwest Stroke Conference 2019.This conference is the fruit of a collaboration of the regional NHS trusts and health professionals and is organized in collaboration between the Royal Devon and Exeter NHS Foundation Trust and the University of Exeter Medical School. It brings together leading experts in the field to deliver an exciting and bespoke programme and update in the rapidly changing field of Stroke Medicine. The programme covers a wide range of issues on acute stroke/TIA management and rehabilitation as well as a debate on the regional development in thrombectomy services and an expert overview on the future of stroke services both regionally and nationally.
Details of the speakers and the topics covered can be found within this booklet. In addition, you can
also find details of our sponsors who have made generous contributions to keep down the cost of registration for this event, and we are very grateful to them for their support.
We value your feedback and it is vital for us to continue to improve the conference and its content.
After completing the study day you will receive an e-mail inviting you to provide feedback and this will also allow you access to your CPD points certificate.
We appreciate your contribution and sincerely hope you enjoy participating in this thought-provoking day.
Welcome
Join the conversation and share your thoughts @ExeterMedCPD using #SWStroke2019
We look forward to meeting you.
Professor Martin James, Dr Salim Elyas and Mr Tim AyersOn behalf of the organising committee
SOUTHWEST STROKE CONFERENCE 2019
Organising Committee
Professor Martin James – Consultant Stroke Physician, Royal Devon and Exeter NHS Foundation Trust & Honorary Clinical Professor at the University of Exeter Medical School
Dr Salim Elyas – Consultant Stroke Physician, Royal Devon and Exeter NHS Foundation Trust and Honorary Senior Clinical Lecturer, University of Exeter Medical School
Tim Ayers – Consultant Nurse in Stroke, Royal Devon and Exeter NHS Foundation Trust
Angie Logan – NIHR Clinical Doctoral Research Fellow and Clinical Specialist Physiotherapist Stroke and Neurology in West Cornwall
Clare Gordon – Consultant Nurse Stroke Care, Royal Bournemouth & Christchurch Hospitals NHS Foundation Trust and NIHR Clinical Academic Fellow
Claire Fullbrook-Scanlon – Lead Nurse for Nursing and Midwifery Workforce and Education, Royal United Hospital, Bath and Senior Lecturer, University of the West of England
Caroline Smith – Consultant Nurse / AF clinical Lead for South West Academic Health Science Network
Duncan Goodman – Stroke Association Support Manager - South West
Cecilia Manosa Nyblon – Education and Skills Partnership Development Manager, University of Exeter Medical School
Amy Hall – Commercial and Business Programmes Support, University of Exeter
1
A special thank you to the colleagues who worked together to help facilitate the inaugural Southwest Stroke Conference 2019.
2
Programme for the DayMORNING SESSION
08:30 – 09:00 Registration and refreshments
09:00 – 09:10WELCOME Dr Salim Elyas, Consultant Stroke Physician, Royal Devon and Exeter NHS Foundation Trust & Honorary Clinical Lecturer at the University of Exeter Medical School
09:10 – 09:50The new NICE Guidelines for Acute Stroke and TIA Professor Martin James, Consultant Stroke Physician, Royal Devon and Exeter NHS Foundation Trust & Honorary Clinical Professor at the University of Exeter Medical School
09:50 – 10:30Dementia in Stroke Professor David Llewelyn, University of Exeter Medical School
10:30 – 11:10
KEYNOTE PRESENTATIONFactors influencing the quality and quantity of therapeutic rehabilitation activity after stroke using DXADr David Clarke, Associate Professor in Stroke Care, University of Leeds
11:10 – 11:30 Refreshments Break
11:30 – 12:15Patient-reported outcomes in Stroke Dr Jonathan Hewitt, Clinical Senior Lecturer at Cardiff University & Honorary Consultant Physician at Llandough Hospital
12:15 – 13:00
KEYNOTE PRESENTATIONIntravenous Thrombolysis – Where next? Professor Tom Robinson, Professor of Stroke Medicine & Head of the Department of Cardiovascular Sciences, University of Leicester
AFTERNOON SESSION
13:00 –14:00 Lunch and networking
14:00 – 14:50
Thrombectomy - Neuroscience Centre versus DGH - Debate Professor Andrew Sharp, Consultant Interventional Cardiologist & Honorary Associate Professor in University Hospital of Wales, Cardiff and Dr Marcus Bradley, Consultant Interventional Neuroradiologist & Clinical Lead for Imaging, North Bristol NHS Trust
14:50 – 15:20The FASE study: Stroke survivor’s experiences and perceptions of post stroke fatigue Ms Liz Tremayne-Ward, Clinical Lead for Acute Stroke and Neurology, Royal Cornwall Hospitals NHS Trust
15:20 – 15:40 Refreshments break
15:40 – 16:20Understanding and managing childhood stroke Dr Vijeya Ganesan, Senior Lecturer & Honorary Consultant in Paediatric Neurology at UCL Great Ormond Street Institute of Child Health
16:20 – 17:00
Predicting recovery pathways in the arm after stroke and managing the profoundly affected arm Dr Rhoda Allison, Associate Director of Nursing and Professional Practice, Torbay & South Devon NHS Foundation Trust
17:00 Close
Dr Salim Elyas
Salim is a Consultant Stroke Physician at the Royal Devon and Exeter Hospital and Honorary Senior Clinical Lecturer at the University Of Exeter School of Medicine and Health. He has a special interest in risk prediction in stroke and TIA, Transcranial Doppler and advanced imaging in stroke and neurovascular diseases and cerebral small vessel disease. He completed his PhD research in stroke at the University of Exeter and published and presented his research in peer reviewed journals, national and international meetings and conferences. He is a member of the British Association of Stroke Physicians, European Stroke Organization and World Stroke Congress. Since his appointment in 2014, he continued to contribute to the care of patients admitted with acute stroke and oversees the stroke rehabilitation unit. He is passionate about patient care, medical education and continues active research to advance the understanding of different aspects of stroke medicine and enhance patient care.
9:00 - 9:10 Welcome
Email: [email protected]
Professor Martin James Martin is Consultant Stroke Physician at the Royal Devon & Exeter NHS Foundation Trust, and Honorary Clinical Professor at the University of Exeter Medical School. He trained in Southampton and he completed his research in hypertension in the elderly with Professor John Potter and the late Professor John Swales in Leicester. He has led the East Devon Stroke Service at the Royal Devon and Exeter Hospital, Exeter since 1997, and has been Clinical Director of the South West Cardiovascular Network since 2008. His ongoing research interests in the CLAHRC include improving methods for the prevention of stroke, stroke rehabilitation and operational research in hyperacute stroke care – his work together with Prof Ken Stein and the PenCHORD team has been influential in the implementation of reperfusion treatments for acute stroke in the South West and the rest of the UK. He is Clinical Director of the Stroke Programme and a Visiting Professor at King’s College London, which runs the national stroke audit ‘SSNAP’, and joint editor of the 2016 RCP National Clinical Guideline for Stroke. He has served terms as both President and Honorary Secretary of the British Association of Stroke Physicians.
09:10 – 09:50 The new NICE Guidelines for Acute Stroke and TIA
Speaker Biographies
3
4
Learning outcomes
• Evidence base for reperfusion treatments in acute stroke• Changes in the management of suspected TIA• Areas where practice has changed since previous NICE Guideline
Email: [email protected]
Professor David Llewellyn
David is an Associate Professor at the University of Exeter Medical School and a Fellow at the Alan Turing Institute. He also holds an honorary contract with Devon Partnership NHS Trust. He moved to Exeter in 2009 having received advanced training in epidemiology and data science as a Research Associate at the University of Cambridge. His research aims to enhance the timely detection of dementia, with a focus on developing strategies for primary and secondary prevention using machine learning. He uses a combination of evidence synthesis, data science and machine learning to develop new translational insights to identify more effective interventions and enhance the diagnostic pathway for dementia. He is an expert on the evaluation of cognitive function and dementia and is a member of the scientific advisory boards of the English Longitudinal Study of Ageing and the UCL Centre for Longitudinal Studies. He sits on Alzheimer’s Research UK’s Grant Review Board and their Clinical Policy Advisory Panel. David is also the Exeter Institute for Data Science and Artificial Intelligence Clinical Theme Lead and the Turing Exeter University Clinical Lead.
09:50 – 10:30 Dementia in Stroke
Learning outcomes• Stroke is a strong independent and potentially modifiable risk factor for dementia• The importance of Alzheimer’s pathology is often overplayed, and most cases of dementia
reflect a mixed underlying pathology• New types of data such as polygenic risk scores and new analytic techniques such as machine
learning provide powerful tools to advance our understanding.
Email: [email protected] @DrDJLlewellyn
Dr David Clarke
Associate Professor in Stroke Care, Academic Unit of Elderly Care and Rehabilitation, Institute of Health Sciences University of Leeds, UK.
David works within the Academic Unit of Elderly Care and Rehabilitation, which is part of the Institute of Health Sciences at the University of Leeds, UK. He is an experienced qualitative researcher working primarily in the area of stroke rehabilitation. David has a keen interest in how health professionals in stroke services understand and manage their work. He was Chief Investigator for the National Institute for Health Research (NIHR) funded ReAcT study which examined factors influencing therapy provision to meet National Clinical Guideline recommendations in eight stroke units in England. The findings of this study have attached the attention of clinicians and researchers in Australia, Canada, Ireland and the Netherlands.
David was lead for the Yorkshire region for the NIHR Health Services and Delivery Research programme funded CREATE study which used co-production methods to enable stroke survivors, caregivers and health professionals to collaborate in the design and implementation of interventions to increase activity for inpatient stroke survivors. He is also the lead for the qualitative and process evaluation studies on two NIHR funded Programme Grants for Applied Research. These are the RECREATE study which is investigating ways to reduce sedentary behaviour after stroke (Chief Investigator Professor Anne Forster) and the HERO study, a large individually randomised controlled trial of a home based exercise programme for older adults with frailty (Chief Investigator Dr Andrew Clegg).
Previously, David led the process evaluation team for the Training Caregivers after Stroke (TRACS) trial, and has conducted research examining the work of nurses in stroke rehabilitation teams.
Academic and Professional Qualifications: PhD (Sociology and Social Policy, Leeds), MSc in Health Sciences, BSc in Nursing Studies, Certificate in Education, RN, RMN.
10:30 – 11:10 Factors influencing the quality and quantity of therapeutic rehabilitation activity after stroke
Learning outcomes• Understand the professional and organisation factors influencing the frequency and intensity of
therapy provision after stroke• Appreciate the ways in which factors influencing the frequency and intensity of therapy
provision after stroke have been addressed in stroke services• Develop knowledge of the use of the Experience-Based Co-Design process in improving
activity levels and inpatient experiences after stroke
Email: [email protected] @DavidJClarke6
55
KEY
NO
TE
PR
ESEN
TAT
ION
66
Dr Jonathan Hewitt
Jonathan has been a Clinical Senior Lecturer in Geriatric Medicine at Cardiff University and an Honorary Consultant Stroke, Geriatric and general Physician for the Anuerin Bevan Health Board, since September 2012. His career combines service, teaching and research. He runs a clinical team in Caerphilly and is course director for the MSc in Ageing Health and Disease in Cardiff University.
Following medical school in London, he trained in geriatric and general medicine in East Anglia. During that time he was awarded an NHS Research and Development Fellowship, which funded an MSc in Epidemiology and subsequent PhD in Diabetes in the Older Person, at the London School of Hygiene and Tropical Medicine.
He has two primary research interests. The first is stroke; primarily patient relevant outcomes and epidemiology. The second is surgical epidemiology in Older People. This work can be seen as part of the Older Persons Surgical Outcomes Collaboration, which I co-founded www.opsoc.eu.
He is also interested in large scale databases and Biobanking, especially the UK Biobank. His interest in the UK Biobank stems from his role as the Vice Chairman of their Ethics and Governance Council, http://www.egcukbiobank.org.uk/, having served as a member of the committee between 2009 - 2017. His interest in research ethics also involves being Chairman of the Cardiff School of Medicine Research Committee. He therefore has a high level of understanding of the importance and governance of large scale data collection, the issues surrounding data security and essential need for public confidence and engagement in data management.
He is the immediate past Chair of The British Geriatrics Society in Wales. He is a member of the academic committee of both the British Association of Stroke Physicians and the British Geriatric Society. He serves on the Joint Committee for Stroke at the Royal College of Physicians and for the last 4 years has been the NHCRW (NIHR) Stroke Lead for Wales, where he has overseen more than a tripling of Welsh recruitment into portfolio adopted studies.
11:30 – 12:15 Patient-reported outcomes in Stroke
Learning outcomes• An overview of Outcome Measures• Patient reported outcome measures• Stroke specific outcome measures
Email: [email protected] @CUGeriMSc
7
Professor Thompson Gordon Robinson
Tom undertook his medical training in Nottingham, Newcastle-Upon-Tyne and Leicester, and is currently Head of the Department of Cardiovascular Sciences and Professor of Stroke Medicine at the University of Leicester, and also an Honorary Consultant Physician in Stroke Medicine for University Hospitals of Leicester NHS Trust. He was appointed an NIHR Senior Investigator in April 2016.
His other responsibilities include: Chair of the Membership Committee of the European Stroke Organisation, President of the British Association of Stroke Physicians, and National Specialty Lead for Stroke for the NIHR Clinical Research Network.
His research interests include clinical trials in acute stroke, particularly blood pressure and thrombolysis management, and studies of cardiovascular and cerebrovascular regulatory mechanisms. His research is currently funded by the British Heart Foundation, the Stroke Association, the Engineering and Physical Sciences Research Council, and the National Institute of Health Research.
12:15 – 13:00 Intravenous Thrombolysis: Where Next?
Learning outcomes• Understand strategies to improve safety of IVT, including alteplase dose and intensity of blood
pressure reduction. • Consider alternatives to alteplase for IVT, including tenecteplase. • Consider new indications for IVT, including wake-up stroke
Email: [email protected]
KEY
NO
TE
PR
ESEN
TAT
ION
8
Professor Andrew Sharp
Andrew qualified from Edinburgh Medical School in 1998. He was appointed as a Consultant Cardiologist at the Royal Devon and Exeter Hospital in 2011 and Honorary Associate Professor by the University of Exeter in 2018 before moving to the University Hospital of Wales in the summer of 2019.
He conducted his early training at the Royal Infirmary of Edinburgh, before moving to London for his senior clinical training. He completed the prestigious Milan-Imperial Interventional Cardiology Fellowship programme, having spent a year in San Raffaele and Columbus Hospitals, Milan, Italy, under the tutelage of Professor Antonio Colombo. He also spent three years training in interventional cardiology at St Mary’s Hospital and The Hammersmith Hospital (Imperial College Hospitals) in London.
Dr Sharp was awarded an MD postgraduate research degree from the University of Edinburgh for his work on the hypertensive heart and currently leads a large research programme at the Royal Devon and Exeter Hospital. He has been Principal Investigator in more than 30 ethically-approved research trials since 2012 and has published extensively. He has an international reputation for leading the development of device-based treatments for hypertension (in particular that of renal denervation) and pulmonary embolism, as well as the advancement of intracoronary imaging and physiology.
Dr Marcus Bradley
Marcus is a graduate of St Mary’s Hospital Medical School in London and has a strong track record within Neurosciences at both an undergraduate and a postgraduate level. He began training in Neuroradiology in 2005 and was appointed as Consultant at North Bristol NHS Trust in 2008. During this time he has been a member of the global Interventional Neuroradiology community that has taken endovascular treatment of acute stroke from a range of experimental procedures through to being a highly effective medical intervention, now the proven standard of care for large vessel occlusion. Interventional Neuroradiology is a highly specialised area of medical practice primarily involved in the endovascular treatment of intracranial vascular pathologies including aneurysms, arteriovenous malformations, and dural arteriovenous fistulae, providing an alternative or adjunct to open neurosurgery. The expertise he has acquired in this practice has been an essential foundation on which he has built and helped develop treatments for stroke and it also the reason stroke thrombectomy has naturally developed within Neuroscience centres. He is a committed trainer of the next generation of Neuroradiologists and was Training Programme Director for Radiology in the Severn region for 6 years, a period which saw an expansion in the number of Neuroradiology training places. He completed an MBA at Imperial College Business School over the last 2 years alongside his full-time clinical and managerial responsibilities. He has taken on further senior management roles and is currently Consultant Interventional Neuroradiologist and Clinical Lead for Imaging at North Bristol NHS Trust, focusing on service development, and a Committee Member of the Healthcare Professional Interest Network at Imperial College Business School.”
9
14:00 –14:50 Thrombectomy-Neuroscience centre versus DGH - Debate
Learning outcomes• Which factors affect outcomes in stroke
thrombectomy patients?• Which areas of the country may require
new approaches?• How would new teams form?• Is this really ‘blue skies’ thinking?
• The requirements for a stroke thrombectomy service
• The training implications for endovascular treatment of stroke
• Service sustainability and geographical equity
Email: [email protected] – Email: [email protected]
Ms Liz Tremayne-Ward Liz is the Clinical Lead Occupational Therapist in Acute Stroke and Neurology at the Royal Cornwall Hospital. She has recently completed her MSc in clinical research with a specific focus on post stroke fatigue. She has a keen interest in research, developing her own research skills and supporting the development of other professionals. She facilitates the county occupational research interest group (ROTTERS) and is a Council of Allied Health Research representative (CAPHR) for her Trust, promoting the active engagement of AHPs in research. She also peer reviews for MSc colleagues and has collaborated with PhD research studies. Following her MSc she was also appointed an honorary clinical fellow for the Peninsular Clinical School and sits on the leadership management committee.
As part of a collaborative multidisciplinary partnership, she has been involved in supporting the development of stroke services in Sudan. As a result of this project, she is an active part of a national group of stroke practitioners with an interest in stroke within low and middle income countries.
14:50 – 15:20 The FASE study: Stroke survivor’s experiences and perceptions of post stroke fatigue
Learning outcomes• Understand the concept and impact of PSF from stroke survivors’ perspective• Become aware of stroke survivors’ current experience of PSF education from the FASE study• Develop awareness of stroke survivors’ perceptions of what PSF education should include from the FASE study.
Email: [email protected] @TremayneLiz
10
Dr Vijeya Ganesan
Vijeya is Senior Lecturer and Honorary Consultant in Paediatric Neurology at UCL Great Ormond Street Institute of Child Health. She leads a multidisciplinary paediatric neurovascular service and has undertaken research in this field for over 20 years. She chaired the guideline development group for the 2017 RCPCH Paediatric Stroke Guideline Development group.
15:40 – 16:20 Understanding and manging childhood stroke
Learning outcomes• Understand key risk factors for childhood arterial ischaemic stroke• Understand key differences in these between children and adults• Consider the scientific, clinical and practical issues around hyperacute stroke care for children
Email: [email protected]
Dr Rhoda Allison Rhoda was the first Consultant Physiotherapist in Stroke in the UK, and developed the stroke and neurorehabilitation services in Torbay and South Devon NHS Foundation Trust.
She has recently moved to the role of Associate Director of Nursing & Professional Practice but continues to work clinically including spasticity management.
16:20 – 17:00 Predicting recovery pathways in the arm after stroke and managing the profoundly affected arm
Learning outcomes• Understand longitudinal profile of the arm after stroke• Understand risk factors in the profoundly affected arm• Consider management of the profoundly affected arm
Email: [email protected]
www.rdehospital.nhs.uk RDEhospitals @RDEhospitals
11
The Royal Devon and Exeter NHS Foundation Trust provides integrated health and care services across Exeter and East and Mid Devon. With 8,000 staff, it manages a large acute teaching hospital, 12 community hospitals and provides community services to a core population of over 450,000.
The Trust is nationally and internationally recognised for excellence in a number of specialist fields including the Princess
Elizabeth Orthopaedic Centre, the Centre for Women’sHealth (maternity, neonatology and gynaecology services), Cancer Services, Renal Services, Exeter Mobility Centre and Mardon Neurorehabilitation Centre.
In 2015, the Care Quality Commission rated the Trust as ‘good’ overall with many areas, including caring, emergency care and critical care, recognised as ‘outstanding’.
Our Collaborators
medicine.exeter.ac.uk ExeterMed @ExeterMed
The College of Medicine and Health isimproving the health of the South West andbeyond, through the development of highquality graduates and world-leading researchthat has international impact. It encompassesthe Medical School, Academy of Nursing andthe department of Allied Health Professions.As part of a Russell Group university, wecombine this world-class research with veryhigh levels of student satisfaction. Our Medicineprogramme is ranked 9th in the Times andThe Sunday Times Good University Guide 2019,while Medical Imaging is Top 5 in both theTimes and The Sunday Times Good UniversityGuide 2019 (under Radiography) and theComplete University Guide 2020 (underMedical Technology).
Exeter has over 19,000 students and is ranked12th in the Times and The Sunday Times GoodUniversity Guide 2019 and 11th in the CompleteUniversity Guide 2020. In the 2014 ResearchExcellence Framework (REF), the Universityranked 16th nationally, with 98% of its researchrated as being of international quality. Exeter’sClinical Medicine research was ranked 3rdin the country, based on research outputsthat were rated world-leading. Public Health,Health Services and Primary Care research alsoranked in the top ten, in joint 9th for researchoutputs rated world-leading or internationallyexcellent. Exeter was named the Times andThe Sunday Times Sports University of theYear 2015-16, in recognition of excellence inperformance, education and research.
19 12
Daiichi Sankyo
Daiichi Sankyo UK Ltd is a Japanese pharmaceutical company that creates and supplies innovative products to help the NHS to deliver better patient care. We specialise in the fields of cardiovascular disease and oncology. We provide medicines and support to the NHS to improve people’s lives every day.
Our SponsorsA special thanks to our sponsors who are supporting the Southwest Stroke Conference with an exhibition stand.
www.daiichisankyo.com
Bayer
Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time.
We focus on researching and developing speciality-focused innovative medicines primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and opthamology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies within the NHS.
www.bayer.com
Pfizerwww.pfizer.co.uk
South West Academic Health Science Network
The South West Academic Health Science Network (SW AHSN) supports the spread and adoption of innovation in health and care. One of 15 AHSNs across the country set up by NHS England to identify, adopt and share innovative healthcare, the SW AHSN brings together like-minded people from academia, industry, life sciences, local government and the voluntary sector to work with the NHS in pursuit of a common goal – to improve the health and wellbeing of people in the region.
The Office for Life Sciences funds our Innovation Exchange and NHS Improvement commission the National Patient Safety Collaborative Programme, which is delivered by AHSNs. An example of our work is within the national remit we have rolled out mobile Atrial Fibrillation (AF) detection devices to primary care since March 2018. These devices have been used over 3,800 times and have picked up over 200 people with possible AF.
North Bristol NHS Trust
North Bristol NHS Trust is one of the largest hospital trusts in the South West, providing hospital and community healthcare to the residents of Bristol, South Gloucestershire and North Somerset. Our stroke service is based at Southmead Hospital, Bristol in our state-of-the-art Brunel Building.
Since 2017, the Trust has led a specialised acute stroke centre, treating patients from across the West of England and is currently the third busiest Thrombectomy service in the country. With extra national investment and staff training, the Trust is aiming to expand to a 24-hour service, seven days a week.
www.swahsn.com
www.nbt.nhs.uk
13
19 14
Useful ResourcesNICE Guidelines – Stroke & Transient Ischaemic Attackwww.nice.org.uk/guidance/conditions-and-dis-eases/cardiovascular-conditions/stroke-and- transient-ischaemic-attack
Stroke Associationwww.stroke.org.uk
European Stroke Associationeso-stroke.org
Exeter Health Library – Stroke Twitter listtwitter.com/RDELibrary/lists/stroke
Royal College of Physicians – Stroke Medicinewww.rcplondon.ac.uk/education-practice/ advice/specialty-spotlight-stroke-medicine
American Stroke Associationwww.stroke.org
The College of Medicine and Health atthe University of Exeter offers a range ofimpactful and innovative Postgraduate Taught programmes, Short Courses and Continuing Professional Development opportunities. These aim to equip healthcare professionals withthe advanced skills and knowledge theyneed to make a positive contribution to the delivery of care.
Covering an array of highly relevant themes from allergies and genomics to extreme medicine and applied health services, our programmes facilitate and effect real change in the quality of clinical care and health for individuals and the wider community.
Designed to attract multi-professionalinterest from across the healthcare sectorour research-inspired and evidence-basedprogrammes continue to reflect high quality, safe and effective healthcare.
Postgraduate Short Courses and ContinuingProfessional Development at the College of Medicine and Health at the University of Exeter
Website www.exeter.ac.uk/medicineEmail [email protected]
@ExeterMed @ExeterMedCPD
/UoEMed #WeAreAllExeter
2019
UEM
S034
COLLEGE OF MEDICINE AND HEALTH
Contact usWe are here to help you with specialist advice, guidance and support when you need a more individual service.
For CPD opportunities contact: 01392 722964
@ExeterMedCPD
or visit us at: medicine.exeter.ac.uk/cpd
For Postgraduate Taught Porgrammes contact:
Or visit us at: medicine.exeter.ac.uk/study/pgt
